My general framework: Start with semaglutide if cost is a significant concern, or if there is no strong reason to expect poor tolerance Start with tirzepatide if the patient has tried semaglutide before and struggled with side effects, if faster initial response matters clinically, or if the patients goals require larger total weight loss Switch to tirzepatide if a patient on semaglutide is experiencing persistent nausea or has plateaued and escalation options are limited One pattern worth noting: men I see a consistent pattern with male patients who struggle to tolerate semaglutide nausea and GI disruption can be particularly disruptive for them, and theyre often less willing to push through it
Internetska stranica upotrebljava kolaie uz pomo kojih poboljavamo korisniko iskustvo i osiguravamo vam sadraj
So even if the medications themselves represent good value for society, that does not mean we, as a society, can take the impact of how many individuals would use this. According to the Centers for Disease Control and Prevention , some 40% of Americans are obese
The result is unnecessary side effects, muscle loss, malnutrition, and people quitting treatment entirely because they were pushed too hard too fast
